AstraZeneca PLC is 81.5x more valuable than Organon & Co. by market capitalization ($286.27 B vs $3.51 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OGN | AZN |
|---|---|---|
| Market cap | $3.51 B | $286.27 B |
| US-listed rank | #1688 | #45 |
| Revenue (latest FY) | $6.22B | - |
| Net income (latest FY) | $187.00M | - |
| Net margin | 3.0% | - |
| P/E (trailing FY) | 18.8 | - |
| SEC filings | 433 | 1,004 |
AstraZeneca PLC is 81.5x more valuable than Organon & Co. by market capitalization ($286.27 B vs $3.51 B).
Full pages: Organon & Co. and AstraZeneca PLC, or browse the full rankings.